These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis. Jivcu C, Gotfried M. Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863 [Abstract] [Full Text] [Related]
68. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis. Van Royen P, Betz W, Heyrman J, Taziaux P, Van den Haute M, Poelman M. J Int Med Res; 1997 Aug; 25(1):33-40. PubMed ID: 9027671 [Abstract] [Full Text] [Related]
70. Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones? Obaji A, Sethi S. Drugs Aging; 2001 Aug; 18(1):1-11. PubMed ID: 11232735 [Abstract] [Full Text] [Related]
72. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C. J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313 [Abstract] [Full Text] [Related]
73. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. Mertens JC, van Barneveld PW, Asin HR, Ligtvoet E, Visser MR, Branger T, Hoepelman AI. Antimicrob Agents Chemother; 1992 Jul; 36(7):1456-9. PubMed ID: 1324645 [Abstract] [Full Text] [Related]
74. Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin. Ferguson BJ, Anon J, Poole MD, Hendrick K, Gilson M, Seltzer EG, Gemifloxacin 186 Study Group. Otolaryngol Head Neck Surg; 2002 Jul; 127(1):1-6. PubMed ID: 12161723 [Abstract] [Full Text] [Related]
75. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. Wilson R, Kubin R, Ballin I, Deppermann KM, Bassaris HP, Leophonte P, Schreurs AJ, Torres A, Sommerauer B. J Antimicrob Chemother; 1999 Oct; 44(4):501-13. PubMed ID: 10588312 [Abstract] [Full Text] [Related]
77. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis. Martinot JB, Carr WD, Cullen S, Heredia Budo JL, Bauer K, MacLeod C, Sanguinetti CM, van Veldhuizen WC, Clarithromycin Once-a-Day Study Group. Adv Ther; 2001 Oct; 18(1):1-11. PubMed ID: 11512528 [Abstract] [Full Text] [Related]
78. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. Periti P, Novelli A, Schildwachter G, Schmidt-Gayk H, Ryo Y, Zuck P. J Antimicrob Chemother; 1990 Dec; 26 Suppl E():63-9. PubMed ID: 2292532 [Abstract] [Full Text] [Related]
79. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials. Zeckel ML. Am J Med; 1992 Jun 22; 92(6A):58S-64S. PubMed ID: 1621746 [Abstract] [Full Text] [Related]